MainSleaze

Cellectis SA, a worldwide pioneer in Genome engineering, is spamming addresses harvested from scientific publications. The ESP is EmailVision, whose anti-spam policy unequivocally prohibits the sending of unsolicited emails.

Spamming IP: 81.92.123.13

Spam headers:

Return-Path: <bioresearch-ealert@bioresearch.cellectis.com>
Received: from mercure-onthei.ccemails.net (mercure-onthei.ccemails.net [81.92.123.138])
by x (8.14.4/8.14.4) with ESMTP id x
for <x>; Tue, 7 Feb 2012 15:0x:xx +0200
DKIM-Signature: v=1; a=rsa-sha1; c=relaxed/relaxed; s=emv; d=bioresearch.cellectis.com;
h=Date:From:Reply-To:To:Message-ID:Subject:MIME-Version:Content-Type:List-Unsubscribe; i=bioresearch-ealert@bioresearch.cellectis.com;
bh=X+PNu88Q6INR9E7xW5jmf2iRw/Q=;
b=AGZfqjK3gPj0n2MvcMzIKzEvVL/2o1Zz0tC8qcEG9hn0A3+JrO3oWOcJkLYl/9Q1YOFK/4r2ypi4
TictgXSOLA==
Received: by mercure-onthei.ccemails.net id x for <x>; Tue, 7 Feb 2012 13:5x +0100 (envelope-from <bioresearch-ealert@bioresearch.cellectis.com>)
Date: Tue, 7 Feb 2012 14:0x:xx +0100 (CET)
From: "Luc Selig, Ph.D." <bioresearch-ealert@bioresearch.cellectis.com>
Reply-To: Luc Selig <enquire03@cellectis-bioresearch.com>
To: =?iso-8859-15?Q?Dr_X?= <x>
Message-ID: <x.x.x@p1enginex2.emv2.com>
Subject: =?iso-8859-15?Q?Cellectis_bioresearch_TALEN=AE_Hit(TM):_as?=
=?iso-8859-15?Q?sess_now_your_sequence_for_TALEN=AE_hits!_?=
MIME-Version: 1.0
Content-Type: multipart/alternative; boundary=x
X-EMV-Platform: cce.campaigncommander.com$
X-EMV-CampagneId: x$
X-EMV-MemberId: x$
List-Unsubscribe: http://tre.emv3.com/HD?a=x

Human-readable spam contents:

     If you cannot view this message, follow this link.
http://tre.emv3.com/HM?a=x

TALEN® Hit(TM)
http://tre.emv3.com/HS?a=x

Dear Dr.,

Cellectis bioresearch has just launched its exclusive TALEN® Hit(TM)
http://tre.emv3.com/HS?a=x
software, freely available to show the universality of our TALENs®,
the next generation gene customization tools!

Cellectis bioresearch’s TALENs® open new fields of research
applications, as powerful tools for gene knock-
out and targeted modification of genomes. They are able to bind to
any gene and introduce a DNA double
strand break at any position, in any genome.

TALEN® Hit(TM) identifies hits typically every 2 to 3 nucleotides on
any target sequence, which makes previously unachievable projects,
now possible.

Do you have a genome modification project? Do you want to explore new
genomic possibilities?

>> Check out now if your sequence’s got talent: use our TALEN®
Hit(TM) software and take advantage of our affordable TALEN®
Access(TM) service offer!
http://tre.emv3.com/HS?a=x
http://tre.emv3.com/HS?a=x

To place an order and to discuss your project in greater details with
our technical experts, please enquire now.
mailto:sales03@cellectis-bioresearch.com?subject=Enquiry%20TALEN®%20Hit(TM)%20search

No limit, just talent
>> Genome editing with engineered nucleases – Nature Methods’ Method of the Year 2011 !
http://tre.emv3.com/HS?a=x

With my best regards,
Luc Selig, PhD
VP Sales & Marketing
Cellectis bioresearch

Life Science Awards WINNER 2011
http://tre.emv3.com/HS?a=x
———————————————————————

Visit our Website
http://tre.emv3.com/HS?a=x
Contact us
mailto:sales03@cellectis-bioresearch.com?subject=Enquiry%20TALEN®%20Hit(TM)%20search

If you do not wish to receive further email from us, please
Unsubscribe.
http://tre.emv3.com/HD?a=x
Your personal data are subject to processing. This processing is used
exclusively for selection of prospective partners and/or for
commercial prospecting. In compliance with the French law “Loi
n78-17 du 6 janvier 1978 relative * l’informatique aux fichiers et
aux libertes”, you have the right of access, the right of opposition
and the right of modification of his personal data. To use these
rights, you shall contact at the following address: Cellectis
bioresearch ? 8, rue de la Croix Jarry, 75013 Paris.